Scientific Papers

Prognostic significance of HLA-G in patients with colorectal cancer: a meta-analysis and bioinformatics analysis | BMC Cancer


  • Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.

    Article 
    PubMed 

    Google Scholar
     

  • Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145–64. https://doi.org/10.3322/caac.21601.

    Article 
    PubMed 

    Google Scholar
     

  • Fan A, Wang B, Wang X, Nie Y, Fan D, Zhao X, Fan A, Wang B, Wang X, Nie Y, Fan D, Zhao X, Lu Y. Immunotherapy in colorectal cancer: current achievements and future perspective. Int J Biol Sci. 2021;17(14):3837–49. https://doi.org/10.7150/ijbs.64077.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Lichtenstern CR, Ngu RK, Shalapour S, Karin M. Immunotherapy, inflammation and colorectal cancer. Cells. 2020;9(3): 618. https://doi.org/10.3390/cells9030618.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Guraya SY. Pattern, stage, and time of recurrent colorectal cancer after curative surgery. Clin Colorectal Cancer. 2019;18(2):e223–8. https://doi.org/10.1016/j.clcc.2019.01.003.

    Article 
    PubMed 

    Google Scholar
     

  • Geraghty DE, Koller BH, Orr HT. A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment. Proc Natl Acad Sci U S A. 1987;84(24):9145–9. https://doi.org/10.1073/pnas.84.24.9145.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science. 1990;248(4952):220–3. https://doi.org/10.1126/science.2326636.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Xu X, Zhou Y, Wei H. Roles of HLA-G in the maternal-fetal immune microenvironment. Front Immunol. 2020;11: 592010. https://doi.org/10.3389/fimmu.2020.592010.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zhuang B, Shang J, Yao Y. HLA-G: an important mediator of maternal-fetal immune-tolerance. Front Immunol. 2021;12:744324. https://doi.org/10.3389/fimmu.2021.744324.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Carosella ED, Rouas-Freiss N, Tronik-Le Roux D, Moreau P, LeMaoult J. HLA-G: an immune checkpoint molecule. Adv Immunol. 2015;127:33–144. https://doi.org/10.1016/bs.ai.2015.04.001.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Morandi F, Pistoia V. Interactions between HLA-G and HLA-E in physiological and pathological conditions. Front Immunol. 2014;5:5. https://doi.org/10.3389/fimmu.2014.00394.

    Article 
    CAS 

    Google Scholar
     

  • Krijgsman D, Roelands J, Hendrickx W, Bedognetti D, Kuppen PJK. HLA-G: a new immune checkpoint in cancer? Int J Mol Sci. 2020;21(12):4528. https://doi.org/10.3390/ijms21124528.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Attia JVD, Dessens CE, van de Water R, Houvast RD, Kuppen PJK, Krijgsman D, Attia JVD, Dessens CE, van de Water R, Houvast RD, Kuppen PJK, Krijgsman D. The Molecular and functional characteristics of HLA-G and the Interaction with its receptors: where to intervene for cancer immunotherapy? Int J Mol Sci. 2020;21(22): 8678. https://doi.org/10.3390/ijms21228678.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Paul P, Rouas-Freiss N, Khalil-Daher I, Moreau P, Riteau B, Le Gal FA, Paul P, Rouas-Freiss N, Khalil-Daher I, Moreau P, Riteau B, Le Gal FA, Avril MF, Dausset J, Guillet JG, Carosella ED. HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci U S A. 1998;95(8):4510–5. https://doi.org/10.1073/pnas.95.8.4510.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Xu HH, Gan J, Xu DP, Li L, Yan WH. Comprehensive transcriptomic analysis reveals the role of the Immune checkpoint HLA-G molecule in cancers. Front Immunol. 2021;12: 614773. https://doi.org/10.3389/fimmu.2021.614773.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Lin A, Yan WH. Intercellular transfer of HLA-G: its potential in cancer immunology. Clin Transl Immunology. 2019;8(9):e1077. https://doi.org/10.1002/cti2.1077.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Yan WH. Human leukocyte antigen-G in cancer: are they clinically relevant? Cancer Lett. 2011;311(2):123–30. https://doi.org/10.1016/j.canlet.2011.07.019.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Ye SR, Yang H, Li K, Dong DD, Lin XM, Yie SM. Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer. Mod Pathol. 2007;20(3):375–83. https://doi.org/10.1038/modpathol.3800751.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Reimers MS, Engels CC, Putter H, Morreau H, Liefers GJ, van de Velde CJ, Reimers MS, Engels CC, Putter H, Morreau H, Liefers GJ, van de Velde CJH, Kuppen PJK. Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: a retrospective cohort study. BMC Cancer. 2014;14(1): 486. https://doi.org/10.1186/1471-2407-14-486.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71. https://doi.org/10.1136/bmj.n71.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27–30. https://doi.org/10.1093/nar/28.1.27.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kanehisa M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 2019;28(11):1947–51. https://doi.org/10.1002/pro.3715.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2023;51(D1):D587-d592. https://doi.org/10.1093/nar/gkac963.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Zeestraten EC, Reimers MS, Saadatmand S, Goossens-Beumer IJ, Dekker JW, Liefers GJ, et al. Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients. Br J Cancer. 2014;110(2):459–68. https://doi.org/10.1038/bjc.2013.696.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Guo ZY, Lv YG, Wang L, Shi SJ, Yang F, Zheng GX, Guo Z-Y, Lv Y-G, Wang L, Shi S-J, Yang F, Zheng G-X, Wen W-H, Yang A-G. Predictive value of HLA-G and HLA-E in the prognosis of colorectal cancer patients. Cell Immunol. 2015;293(1):10–6. https://doi.org/10.1016/j.cellimm.2014.10.003.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Kirana C, Ruszkiewicz A, Stubbs RS, Hardingham JE, Hewett PJ, Maddern GJ, et al. Soluble HLA-G is a differential prognostic marker in sequential colorectal cancer disease stages. Int J Cancer. 2017;140(11):2577–86. https://doi.org/10.1002/ijc.30667.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Li JB, Ruan YY, Hu B, Dong SS, Bi TN, Lin A, Li J-B, Ruan Y-Y, Hu B, Dong S-S, Bi T-N, Lin A, Yan W-H. Importance of the plasma soluble HLA-G levels for prognostic stratification with traditional prognosticators in colorectal cancer. Oncotarget. 2017;8(30):48854–62. https://doi.org/10.18632/oncotarget.16457.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zhang RL, Zhang X, Dong SS, Hu B, Han QY, Zhang JG, Zhang R-L, Zhang X, Dong S-S, Hu B, Han Q-Y, Zhang J-G, Zhou W-J, Lin A, Yan W-H. Predictive value of different proportion of lesion HLA-G expression in colorectal cancer. Oncotarget. 2017;8(64):107441–51. https://doi.org/10.18632/oncotarget.22487.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Samadi R, Mojarad EN, Molaei M, Kazerouni F, Aghdaei HA, Navidinia M, et al. Clinical value of Human Leucocyte Antigen G (HLA-G) expression in the prognosis of Colorectal Cancer. Int J Cancer Manage. 2017;10(4). https://doi.org/10.5812/ijcm.9346.

  • Lin A, Zhang X, Zhang RL, Zhang JG, Zhou WJ, Yan WH. Clinical significance of potential unidentified HLA-G isoforms without α1 domain but containing Intron 4 in colorectal cancer patients. Front Oncol. 2018;8: 361. https://doi.org/10.3389/fonc.2018.00361.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Jiao F, Zhou J, Sun H, Song X, Song Y. Plasma soluble human leukocyte antigen G predicts the long-term prognosis in patients with colorectal cancer. Transl Cancer Res. 2020;9(6):4011–9. https://doi.org/10.21037/tcr-20-2211.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Chen QY, Chen YX, Han QY, Zhang JG, Zhou WJ, Zhang X, Chen Q-Y, Chen Y-X, Han Q-Y, Zhang J-G, Zhou W-J, Zhang X, Ye Y-H, Yan W-H, Lin A. Prognostic significance of Immune checkpoints HLA-G/ILT-2/4 and PD-L1 in colorectal cancer. Front Immunol. 2021;12: 679090. https://doi.org/10.3389/fimmu.2021.679090.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bennedsen ALB, Cai L, Hasselager RP, Özcan AA, Mohamed KB, Eriksen JO, Bennedsen ALB, Cai L, Hasselager RP, Özcan AA, Mohamed KB, Eriksen JO, Eiholm S, Bzorek M, Fiehn A-M, Hviid TVF, Gögenur I. An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer. BMC Cancer. 2022;22(1):62. https://doi.org/10.1186/s12885-022-09169-0.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Emirzeoglu L, Olmez O, Mustafayev FNA, Berber U, Yilmaz I, Celik S, et al. Prognostic value of expression levels of miR-148a, miR-152 and HLA-G in colon cancer. Oncol Lett. 2022;24(1):226. https://doi.org/10.3892/ol.2022.13347.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wang H. MicroRNAs and apoptosis in colorectal cancer. Int J Mol Sci. 2020;21(15): 5353. https://doi.org/10.3390/ijms21155353.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bai Z, Zhou Y, Ye Z, Xiong J, Lan H, Wang F. Tumor-infiltrating lymphocytes in colorectal cancer: the fundamental indication and application on immunotherapy. Front Immunol. 2021;12:808964. https://doi.org/10.3389/fimmu.2021.808964.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Shan J, Han D, Shen C, Lei Q, Zhang Y. Mechanism and strategies of immunotherapy resistance in colorectal cancer. Front Immunol. 2022;13: 1016646. https://doi.org/10.3389/fimmu.2022.1016646.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zhou C, Cheng X, Tu S. Current status and future perspective of immune checkpoint inhibitors in colorectal cancer. Cancer Lett. 2021;521:119–29. https://doi.org/10.1016/j.canlet.2021.07.023.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Lin A, Yan WH. Human leukocyte antigen-G (HLA-G) expression in cancers: roles in immune evasion, metastasis and target for therapy. Mol Med. 2015;21(1):782–91. https://doi.org/10.2119/molmed.2015.00083.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Peng Y, Xiao J, Li W, Li S, Xie B, He J, Peng Y, Xiao J, Li W, Li S, Xie B, He J, Liu C. Prognostic and clinicopathological value of human leukocyte antigen G in gastrointestinal cancers: a meta-analysis. Front Oncol. 2021;11: 642902. https://doi.org/10.3389/fonc.2021.642902.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bartolome J, Molto C, Benitez-Fuentes JD, Fernandez-Hinojal G, Manzano A, Perez-Segura P, Bartolome J, Molto C, Benitez-Fuentes JD, Fernandez-Hinojal G, Manzano A, Perez-Segura P, Mittal A, Tamimi F, Amir E, Ocana A. Prognostic value of human leukocyte antigen G expression in solid tumors: a systematic review and meta-analysis. Front Immunol. 2023;14: 1165813. https://doi.org/10.3389/fimmu.2023.1165813.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Lin A, Zhu CC, Chen HX, Chen BF, Zhang X, Zhang JG, et al. Clinical relevance and functional implications for human leucocyte antigen-g expression in non-small-cell Lung cancer. J Cell Mol Med. 2010;14(9):2318–29. https://doi.org/10.1111/j.1582-4934.2009.00858.x.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Yan WH, Liu D, Lu HY, Li YY, Zhang X, Lin A. Significance of tumour cell HLA-G5/-G6 isoform expression in discrimination for adenocarcinoma from squamous cell carcinoma in lung cancer patients. J Cell Mol Med. 2015;19(4):778–85. https://doi.org/10.1111/jcmm.12400.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Tronik-Le Roux D, Renard J, Verine J, Renault V, Tubacher E, LeMaoult J, et al. Novel landscape of HLA-G isoforms expressed in clear cell renal cell carcinoma patients. Mol Oncol. 2017;11(11):1561–78. https://doi.org/10.1002/1878-0261.12119.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Arnaiz-Villena A, Juarez I, Suarez-Trujillo F, López-Nares A, Vaquero C, Palacio-Gruber J, et al. HLA-G: function, polymorphisms and pathology. Int J Immunogenet. 2021;48(2):172–92. https://doi.org/10.1111/iji.12513.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Gan J, Di XH, Yan ZY, Gao YF, Xu HH. HLA-G 3’UTR polymorphism diplotypes and soluble HLA-G plasma levels impact Cervical cancer susceptibility and prognosis. Front Immunol. 2022;13: 1076040. https://doi.org/10.3389/fimmu.2022.1076040.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Rokhafrooz S, Ghadiri A, Ghandil P, Ghafourian M, Hossaini SH, Daraei N, et al. Association between HLA-G 14 bp gene polymorphism and serum sHLA-G protein concentrations in preeclamptic patients and normal pregnant women. Immunol Invest. 2018;47(6):558–68. https://doi.org/10.1080/08820139.2018.1467925.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Martelli-Palomino G, Pancotto JA, Muniz YC, Mendes-Junior CT, Castelli EC, Massaro JD, Martelli-Palomino G, Pancotto JA, Muniz YC, Mendes-Junior CT, Castelli EC, Massaro JD, Krawice-Radanne I, Poras I, Rebmann V, Carosella ED, Rouas-Freiss N, Moreau P, Donadi EA. Polymorphic sites at the 3’ untranslated region of the HLA-G gene are associated with differential hla-g soluble levels in the Brazilian and French population. PLoS One. 2013;8(10): e71742. https://doi.org/10.1371/journal.pone.0071742.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Mori A, Nishi H, Sasaki T, Nagamitsu Y, Kawaguchi R, Okamoto A, Mori A, Nishi H, Sasaki T, Nagamitsu Y, Kawaguchi R, Okamoto A, Kuroda M, Isaka K. HLA-G expression is regulated by miR-365 in trophoblasts under hypoxic conditions. Placenta. 2016;45:37–41. https://doi.org/10.1016/j.placenta.2016.07.004.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Wang Y, Jiang X, Zhang D, Zhao Y, Han X, Zhu L, Wang Y, Jiang X, Zhang D, Zhao Y, Han X, Zhu L, Ren J, Liu Y, You J, Wang H, Cai H. LncRNA DUXAP8 as a prognostic biomarker for various cancers: a meta-analysis and bioinformatics analysis. Front Genet. 2022;13: 907774. https://doi.org/10.3389/fgene.2022.907774.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wang Y, Fu L, Lu T, Zhang G, Zhang J, Zhao Y, Wang Y, Fu L, Lu T, Zhang G, Zhang J, Zhao Y, Jin H, Yang K, Cai H. Clinicopathological and prognostic significance of long non-coding RNA MIAT in human cancers: a review and Meta-analysis. Front Genet. 2021;12: 729768. https://doi.org/10.3389/fgene.2021.729768.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Li TF, Liu J, Fu SJ. The interaction of long non-coding RNA MIAT and miR-133 play a role in the proliferation and Metastasis of pancreatic carcinoma. Biomed Pharmacother. 2018;104:145–50. https://doi.org/10.1016/j.biopha.2018.05.043.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Seliger B. Role of microRNAs on HLA-G expression in human tumors. Hum Immunol. 2016;77(9):760–3. https://doi.org/10.1016/j.humimm.2016.04.006.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Zhang D, An X, Li Z, Zhang S. Role of gene promoter methylation regulated by TETs and DNMTs in the overexpression of HLA-G in MCF-7 cells. Exp Ther Med. 2019;17(6):4709–14. https://doi.org/10.3892/etm.2019.7481.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bucova M, Kluckova K, Kozak J, Rychly B, Suchankova M, Svajdler M, et al. HLA-G 14 bp Ins/Del polymorphism, plasma level of soluble HLA-G, and association with IL-6/IL-10 ratio and survival of glioma patients. Diagnostics (Basel). 2022;12(5):1099. https://doi.org/10.3390/diagnostics12051099.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Whiteside TL. Tumor-infiltrating lymphocytes and their role in solid tumor progression. Exp Suppl. 2022;113:89–106. https://doi.org/10.1007/978-3-030-91311-3_3.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ye L, Zhang T, Kang Z, Guo G, Sun Y, Lin K, Ye L, Zhang T, Kang Z, Guo G, Sun Y, Lin K, Huang Q, Shi X, Ni Z, Ding N, Zhao K-N, Chang W, Wang J, Lin F, Xue X. Tumor-infiltrating immune cells act as a marker for prognosis in colorectal cancer. Front Immunol. 2019;10: 2368. https://doi.org/10.3389/fimmu.2019.02368.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bainbridge DR, Ellis SA, Sargent IL. HLA-G suppresses proliferation of CD4(+) T-lymphocytes. J Reprod Immunol. 2000;48(1):17–26. https://doi.org/10.1016/s0165-0378(00)00070-x.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Köstlin N, Ostermeir AL, Spring B, Schwarz J, Marmé A, Walter CB, et al. HLA-G promotes myeloid-derived suppressor cell accumulation and suppressive activity during human pregnancy through engagement of the receptor ILT4. Eur J Immunol. 2017;47(2):374–84. https://doi.org/10.1002/eji.201646564.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Agaugue S, Carosella ED, Rouas-Freiss N. Role of HLA-G in Tumor Escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17. Blood. 2011;117(26):7021–31. https://doi.org/10.1182/blood-2010-07-294389.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Sieminska I, Baran J. Myeloid-derived suppressor cells in colorectal cancer. Front Immunol. 2020;11:11. https://doi.org/10.3389/fimmu.2020.01526.

    Article 
    CAS 

    Google Scholar
     

  • Zheng G, Jia L, Yang A-G. Roles of HLA-G/KIR2DL4 in breast cancer immune microenvironment. Front Immunol. 2022;13:13. https://doi.org/10.3389/fimmu.2022.791975.

    Article 
    CAS 

    Google Scholar
     

  • Morandi F, Airoldi I. HLA-G and other immune checkpoint molecules as targets for novel combined immunotherapies. Int J Mol Sci. 2022;23(6):2925. https://doi.org/10.3390/ijms23062925.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Carosella ED, Ploussard G, LeMaoult J, Desgrandchamps F. A systematic review of Immunotherapy in Urologic Cancer: evolving roles for targeting of CTLA-4, PD-1/PD-L1, and HLA-G. Eur Urol. 2015;68(2):267–79. https://doi.org/10.1016/j.eururo.2015.02.032.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Gilead buys into Tizona’s anti-HLA-G strategy. Cancer Discov. 2020;10(10):1433. https://doi.org/10.1158/2159-8290.CD-NB2020-077.



  • Source link